The Effects of Lung-Moistening Herbal Medicines on Bleomycin-Induced Pulmonary Fibrosis Mouse Model

被引:4
|
作者
Ahn, Junmo [1 ]
Joo, Hyejin [2 ]
Park, Jihye [3 ]
Park, Jae-Woo [1 ]
Kim, Kwan-Il [1 ]
Jung, Hee-Jae [1 ]
Bu, Youngmin [1 ]
Lee, Beom-Joon [1 ]
机构
[1] Kyung Hee Univ, Coll Korean Med, Seoul 02447, South Korea
[2] Kyung Hee Univ, Grad Sch, Coll Sci Korean Med, Seoul 02447, South Korea
[3] Kyung Hee Univ, Grad Sch, Dept Biomed Sci & Technol, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
pulmonary fibrosis; bleomycin; herbal medicine; broncho alveolar lavage fluid; inflammation; DIAGNOSIS;
D O I
10.3390/pr8010102
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
In traditional medicine, lung-moistening herbal medicines (LMHM) are regarded as a major option for treating symptoms of pulmonary fibrosis (PF) including dry cough and dyspnea. As PF agents are being applied to the development of lung cancer agents, PF and lung cancer are reported to have high pathological and pharmacological relationships. This study was proposed to identify candidates for the treatment of PF via investigating the effect of LMHM on PF mouse model. PF was induced by intratracheal instillation of bleomycin. Six water extracts of LMHM such as Farfarae Flos (FAF), Trichosanthis Semen (TRS), Lilii Bulbus (LIB), Adenophorae Radix (ADR), Asteris Radix (ASR), and Scrophulariae Radix (SCR) were prepared and administered (300 mg/kg) orally for 10 days after induction. The changes in body weight, histopathology, and immune cell of bronchoalveolar lavage fluid (BALF) were investigated. Among those, LIB and ADR significantly decreased the deposition of collagen and septal thickness of alveolar and terminal bronchiole. Moreover, SCR, TRS, LIB, and ADR decreased total cells, macrophages, and lymphocytes in BALF. Taken together, ADR and LIB could be the candidates to reduce PF. Further studies on their effects at different doses and analysis of their underlying molecular mechanisms are needed.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Effects of gefitinib on respiratory functions in a bleomycin-induced pulmonary fibrosis model in mice
    Kawasaki, Yukiko
    Hirasawa, Yasushi
    Otsu, Shoko
    Matsui, Yukari
    Sugiura, Takahiro
    Imai, Jyun
    Toyoshi, Tohru
    Kyuki, Kohei
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 215P - 215P
  • [42] Quantitation of hydroxyproline in a mouse model of bleomycin-induced lung fibrosis: comparison with histological analysis
    Bigatto, Viola
    Manni, Elena
    Pompilio, Daniela
    Brana, Mariapia
    Chalidou, Anna
    Velden, Joachim
    Corsi, Mauro
    Russell, Vince
    Andreetta, Filippo
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [43] Characterization of Lung Stem Cell Niches in a Mouse Model of Bleomycin-Induced Fibrosis.
    Banerjee, E. Ray
    Henderson, W. R., Jr.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [44] Nintedanib Attenuates Lung Function Decline In A Bleomycin-Induced Rat Model Of Pulmonary Fibrosis
    Carrington, R.
    Jordan, S.
    Dewhurst, J.
    Thang, K.
    Curkovic, A.
    Stapleton, N.
    Meecham, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice
    Shi, Keyun
    Jiang, Jianzhong
    Ma, Tieliang
    Xie, Jing
    Duan, Lirong
    Chen, Ruhua
    Song, Ping
    Yu, Zhixin
    Liu, Chao
    Zhu, Qin
    Zheng, Jinxu
    [J]. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2014, 190 (01) : 113 - 117
  • [46] Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model
    Principi, Lucrezia
    Ferrini, Erica
    Ciccimarra, Roberta
    Pagani, Lisa
    Chinello, Clizia
    Previtali, Paolo
    Smith, Andrew
    Villetti, Gino
    Zoboli, Matteo
    Ravanetti, Francesca
    Stellari, Franco Fabio
    Magni, Fulvio
    Piga, Isabella
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [47] Aggravation of bleomycin-induced pulmonary fibrosis in senescence-accelerated mouse
    Lou, Baohui
    Ye, Qiao
    Dai, Huaping
    Huang, Kewu
    Wang, Chen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [48] Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice
    Xiao, JH
    Zhang, JH
    Chen, HL
    Feng, XL
    Wang, JL
    [J]. PLANTA MEDICA, 2005, 71 (03) : 225 - 230
  • [49] Involvement of microRNAs in the development of the bleomycin-induced pulmonary fibrosis model
    Pitozzi, V
    Caruso, P.
    Pittelli, M. G.
    Pontis, S.
    Bonatti, M.
    Ruscitti, F.
    Civelli, M.
    Trevisani, M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [50] Nigella sativa, a traditional Tunisian herbal medicine, attenuates bleomycin-induced pulmonary fibrosis in a rat model
    Abidi, Anouar
    Robbe, Alexandre
    Kourda, Nadia
    Ben Khamsa, Saloua
    Legrand, Alexandre
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 90 : 626 - 637